Acute radiation syndrome (radiological/nuclear incident)
whole-body irradiation · Critical Care / ICU
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
High-dose whole-body ionising radiation causes a dose-dependent syndrome affecting the haematopoietic, gastrointestinal, and neurovascular systems. Time to onset of vomiting and lymphocyte depletion kinetics estimate dose and prognosis; decontamination and supportive care are central.
Red flags
- Vomiting within minutes to one hour of exposure (very high dose)
- Rapid, profound lymphocyte depletion
- Neurological symptoms/hypotension early (neurovascular syndrome, poor prognosis)
- Combined radiation and traumatic injury
- Early erythema (high localised/whole-body dose)
Assessment
Differential diagnosis
- Localised radiation injury
- Internal contamination/incorporation
- Combined radiation-trauma injury
- Chemical exposure
- Sepsis from another cause
- Gastroenteritis
Investigations
- Time to onset of vomiting (prognostic for dose)
- Serial absolute lymphocyte counts (depletion kinetics estimate dose)
- FBC trend (pancytopenia)
- Radiation survey/dosimetry and contamination screening
- Cytogenetic dicentric assay (biodosimetry)
- Assess for internal contamination (nasal/wound swabs, bioassay)
Management
- Ensure responder safety and perform radiological survey; external irradiation alone does not make the patient a hazard, but contamination does
- Treat life-threatening traumatic injuries first (combined injury worsens prognosis)
- Decontaminate: remove clothing (removes most contamination) and wash skin; manage contaminated wounds
- Record the time of onset of nausea and vomiting as a prognostic marker of dose
- Obtain serial lymphocyte counts to estimate absorbed dose and triage
- Provide antiemetics and supportive care for the prodromal phase
- For internal contamination, give specific decorporation agents (e.g. Prussian blue for caesium, DTPA for transuranics, potassium iodide for radioiodine if indicated and timely)
- Manage the haematopoietic syndrome: neutropenic precautions, growth factors (G-CSF), transfusion support, and treat infections aggressively
- Manage the gastrointestinal syndrome: fluid and electrolyte support, nutrition, and infection control for high doses
- Recognise the neurovascular syndrome (very high doses) as generally fatal and provide palliative care
- Coordinate with radiation safety, haematology, and national radiation emergency services
- Plan for mass-casualty triage using dose estimates and resource availability
Drugs & doses
Filgrastim (G-CSF) 5-10 mcg/kg SC daily for the haematopoietic syndrome
Prussian blue 3 g PO three times daily for caesium internal contamination
DTPA (zinc/calcium) IV for transuranic (plutonium/americium) contamination
Potassium iodide 130 mg PO (adult) for radioiodine if indicated and early
Antiemetic (ondansetron 8 mg IV)
Disposition
ICU/haematology with reverse isolation for significant doses; national radiation emergency and radiation safety coordination; mass-casualty triage by estimated dose.
Complications & pitfalls
- Bone marrow failure with infection and haemorrhage
- Gastrointestinal mucosal breakdown and sepsis
- Fatal neurovascular syndrome at very high doses
- Delayed multi-organ and fibrotic effects
- Combined-injury synergy increasing mortality
Exam pearls
- Removing clothing eliminates the majority of external contamination
- Earlier vomiting and faster lymphocyte fall both predict a higher dose and worse prognosis
- An externally irradiated (non-contaminated) patient is not radioactive and poses no risk to staff
- Treat trauma first: combined injury markedly worsens radiation outcomes
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.